6-Bromo-7-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

Tri(pyridin-2-yl)amine, 98%, 250mg

2-(Chloromethyl)-3,5-dimethyl-4-nitropyridine, 95.0%, 250mg

1,4,5,8-Naphthalenetetracarboxylic Acid (contains Monoanhydride)>60.0%(NMR)25g

Ethyl 2,4,5-trifluorobenzoylacetate, 97.0%, 10g

4,7-Dibromo-1H-1,3-benzodiazole, 98%, 250mg

1-Pentanol, min. 98%, for synthesis, 1 L, glass packaging

Trimethylene Sulfide>98.0%(GC)5mL

1-[3,5-bis(trifluoromethyl)phenyl]-3-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]urea, 97%, 100mg

(Z)-2-(benzo[d]thiazol-2-yl)-3-(2-chloro-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)acrylonitrile, 97%, 500mg

1-Allyl-3-(4-methylpyridin-2-yl)thiourea, 1g

(2R,3R,4S,5R)-2,3,4,6-Tetrahydroxy-5-mercaptohexanal, 95.0%, 25mg

2-(2-(4-FLUOROBENZYL)PHENYL)ACETIC ACID, 95.0%, 1g